Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
Cosmos Exploration Limited
ACN 648 890 126
Notice of General Meeting
A General Meeting of the Company will be held as follows:
Time and date:
10:00am (AWST) on Friday, 11 April 2025
In-person:
Suite 1, 295 Rokeby Road, Subiaco WA 6008
The Notice of General Meeting should be read in its entirety.
If Shareholders are in doubt as to how to vote, they should seek advice from their suitably
qualified advisor prior to voting.
Should you wish to discuss any matter, please do not hesitate to contact the Company by
telephone on (08) 6143 6720.
Shareholders are urged to vote by lodging the Proxy Form
Cosmos Exploration Limited
ACN 648 890 126
(Company)
Notice of Annual General Meeting
Notice is hereby given that the general meeting of Shareholders of Cosmos Exploration Limited ACN 648 890
126 (Company) will be held at Suite 1, 295 Rokeby Road, Subiaco WA 6008 on Friday, 11 April 2025 at
10:00am (AWST) (Meeting).
The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that
the persons eligible to vote at the Meeting are those who are registered as Shareholders on Wednesday, 9
April 2025 at 10.00am (AWST).
The Explanatory Memorandum provides additional information on matters to be considered at the Meeting.
The Explanatory Memorandum and the Proxy Form form part of the Notice.
Terms and abbreviations used in the Notice are defined in Schedule 1.
Agenda
1
Resolutions
Resolution 1 – Ratification of issue of Placement Shares
To consider and, if thought fit, to pass with or without amendment, each as a separate ordinary
resolution the following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders
ratify the prior issue of:
(a)
12,000,000 Placement Shares issued under Listing Rule 7.1; and
(b)
8,000,000 Placement Shares issued under Listing Rule 7.1A,
on the terms and conditions in the Explanatory Memorandum.’
Resolution 2 – Approval to issue Director Placement Shares
To consider and, if thought fit, to pass with or without amendment, each as a separate ordinary
resolution the following:
‘That, pursuant to and in accordance with Listing Rule 10.11, section 195(4) of the Corporations Act
and for all other purposes, Shareholders approve the issue of 5,000,000 Director Placement Shares
as follows:
(a)
up to 1,000,000 Director Placement Shares to James Bahen (or his nominee/s); and
(b)
up to 4,000,000 Director Placement Shares to Jeremy Robinson (or his nominee/s),
on the terms and conditions in the Explanatory Memorandum.’
Page 2
Resolution 3 – Approval to issue Lead Manager Options
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, Shareholders
approve the issue of up to 4,000,000 Lead Manager Options to the Lead Manager (or its nominee/s),
on the terms and conditions in the Explanatory Memorandum.’
Resolution 4 – Approval to issue Consideration Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, Shareholders
approve the issue of up to 109,000,000 Consideration Shares pursuant to the EAU Acquisition, on the
terms and conditions in the Explanatory Memorandum.’
Voting exclusions
Pursuant to the Listing Rules, the Company will disregard any votes cast in favour of:
(a)
Resolution 1(a) and (b): by or on behalf of a person who participated in the issue of the
Placement Shares, or any of their respective associates;
(b)
Resolution 2(a): by or on behalf of James Bahen (or his nominee/s), and any other person
who will obtain a material benefit as a result of the issue of these Director Placement Shares
(except a benefit solely by reason of being a Shareholder), or any of their respective
associates;
(c)
Resolution 2(b): by or on behalf of Jeremy Robinson (or his nominee/s), and any other
person who will obtain a material benefit as a result of the issue of these Director Placement
Shares (except a benefit solely by reason of being a Shareholder), or any of their respective
associates;
(d)
Resolution 3: by or on behalf of the Lead Manager (and/or their respective nominee/s), and
any other person who will obtain a material benefit as a result of the issue of these Lead
Manager Options (except a benefit solely by reason of being a Shareholder), or any of their
respective associates; and
(e)
Resolution 4: by or on behalf of the Vendors (and/or their respective nominee/s), and any
other person who will obtain a material benefit as a result of the issue of these Consideration
Shares (except a benefit solely by reason of being a Shareholder), or any of their respective
associates.
The above voting exclusions do not apply to a vote cast in favour of the relevant Resolution by:
(a)
a person as proxy or attorney for a person who is entitled to vote, in accordance with
directions given to the proxy or attorney to vote on the Resolution in that way;
(b)
the Chair as proxy or attorney for a person who is entitled to vote, in accordance with a
direction given to the Chair to vote on the Resolution as the Chair decides; or
Page 3
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not
excluded from voting, and is not an associate of a person excluded from voting, on
the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
BY ORDER OF THE BOARD
Mr Robert Featherby
Joint Company Secretary
Cosmos Exploration Limited
Dated: 13 March 2025
Page 4
Cosmos Exploration Limited
ACN 648 890 126
(Company)
Explanatory Memorandum
1.
Introduction
The Explanatory Memorandum has been prepared for the information of Shareholders in
connection with the business to be conducted at the Meeting to be held at Suite 1, 295
Rokeby Road, Subiaco WA 6008 on Friday, 11 April 2025 at 10:00am (AWST).
The Explanatory Memorandum forms part of the Notice which should be read in its entirety.
The Explanatory Memorandum contains the terms and conditions on which the Resolutions
will be voted.
The Explanatory Memorandum includes the following information to assist Shareholders in
deciding how to vote on the Resolutions:
Section 2
Action to be taken by Shareholders
Section 3
Resolution 1 – Ratification of issue of Placement Shares
Section 4
Resolution 2 – Approval to issue Director Placement Shares
Section 5
Resolution 3 – Approval to issue Lead Manager Options
Section 6
Resolution 4 – Approval to issue Consideration Shares
Schedule 1
Definitions
Schedule 2
Terms and conditions of Lead Manager Options
A Proxy Form is located at the end of the Explanatory Memorandum.
Page 5
2.
Action to be taken by Shareholders
Shareholders should read the Notice including the Explanatory Memorandum carefully before
deciding how to vote on the Resolutions.
2.1
Voting in person
To vote in person, attend the Meeting on the date and at the place set out above.
2.2
Voting by a corporation
A Shareholder that is a corporation may appoint an individual to act as its representative and
vote in person at the Meeting. The appointment must comply with the requirements of
section 250D of the Corporations Act. The representative should bring to the Meeting
evidence of his or her appointment, including any authority under which it is signed.
2.3
Voting by proxy
A Proxy Form is attached to the Notice. This is to be used by Shareholders if they wish to
appoint a representative (a 'proxy') to vote in their place. All Shareholders are invited and
encouraged to attend the Meeting or, if they are unable to attend in person, sign and return the
Proxy Form to the Company in accordance with the instructions thereon. Lodgement of a
Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in
person.
Please note that:
(a)
a member of the Company entitled to attend and vote at the Meeting is entitled to
appoint a proxy;
(b)
a proxy need not be a member of the Company; and
(c)
a member of the Company entitled to cast two or more votes may appoint two proxies
and may specify the proportion or number of votes each proxy is appointed to
exercise, but where the proportion or number is not specified, each proxy may
exercise half of the votes.
The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy
Forms.
Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify
the way the proxy is to vote on a particular resolution and, if it does:
(a)
the proxy need not vote on a show of hands, but if the proxy does so, the proxy must
vote that way (i.e. as directed);
(b)
if the proxy has 2 or more appointments that specify different ways to vote on the
resolution – the proxy must not vote on a show of hands;
(c)
if the proxy is the Chair of the meeting at which the resolution is voted on – the proxy
must vote on a poll, and must vote that way (i.e. as directed); and
(d)
if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does
so, the proxy must vote that way (i.e. as directed).
Page 6
Section 250BC of the Corporations Act provides that, if:
(a)
an appointment of a proxy specifies the way the proxy is to vote on a particular
resolution at a meeting of the Company's members;
(b)
the appointed proxy is not the chair of the meeting;
(c)
at the meeting, a poll is duly demanded, or is otherwise required under section 250JA
on the resolution; and
(d)
either the proxy is not recorded as attending the meeting or the proxy does not vote on
the resolution,
the Chair of the meeting is taken, before voting on the resolution closes, to have been
appointed as the proxy for the purposes of voting on the resolution at the meeting.
Proxy appointments will only be valid and accepted by the Company if they are made and
received no later than 48 hours before the Meeting.
2.4
Chair's voting intentions
The Chair intends to exercise all available proxies in favour of all Resolutions, unless the
Shareholder has expressly indicated a different voting intention.
2.5
Submitting questions
Shareholders may submit questions in advance of the Meeting to the Company. Questions
must be submitted by emailing the Joint Company Secretaries at robbie@sccperth.com.au by
no later than five business days before the Meeting.
Shareholders will also have the opportunity to submit questions during the Meeting in respect
to the formal items of business. In order to ask a question during the Meeting, please follow
the instructions from the Chair.
The Chair will attempt to respond to the questions during the Meeting. The Chair will request
prior to a Shareholder asking a question that they identify themselves (including the entity
name of their shareholding and the number of Shares they hold).
3.
Resolution 1 – Ratification of issue of Placement Shares
3.1
General
On 5 February 2024, in connection with the EAU Option Agreement (defined below), the
Company announced that it had received firm commitments for a placement to raise
approximately $1,250,000 through the issue of up to 25,000,000 fully paid ordinary shares in
the Company (Shares) at $0.05 per Share (Placement).
The Placement is comprised of:
(a)
20,000,000 Shares to be issued to unrelated parties of the Company (Placement
Shares) comprising:
(i)
12,000,000 Placement Shares issued under Listing Rule 7.1 (the subject of
Resolution 1(a)); and
Page 7
3475-1604-5877, v. 4
(ii)
(b)
8,000,000 Placement Shares issued under Listing Rule 7.1A (the subject of
Resolution 1(b)); and
5,000,000 Shares to be issued to the Directors James Bahen and Jeremy Robinson
(Director Placement Shares), the subject of Resolution 2(a) and (b).
The Company issued the Placement Shares on 14 February 2025 without prior Shareholder
approval using the Company’s available placement capacity under Listing Rules 7.1 and 7.1A.
Yelverton Capital Pty Ltd acted as lead manager to the Placement (Lead Manager).
Resolution 1(a) and (b) (inclusive) seeks the approval of Shareholders pursuant to Listing Rule
7.4 to ratify the issue of the Placement Shares.
3.2
Listing Rules 7.1, 7.1A and 7.4
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of
Equity Securities that a listed company can issue without the approval of its shareholders over
any 12-month period to 15% of the fully paid ordinary shares it had on issue at the start of that
period.
Under Listing Rule 7.1A however, an eligible entity can seek approval from its members, by way
of a special resolution passed at its annual general meeting, to increase this 15% limit by an
extra 10% to 25%. The Company obtained this approval at its annual general meeting held on
6 November 2024.
The issue of the Placement Shares does not fit within any of the exceptions to Listing Rules 7.1
and 7.1A and, as it has not yet been approved by Shareholders, effectively uses up part of the
Company’s 15% placement capacity under Listing Rule 7.1 and 10% placement capacity under
Listing Rule 7.1A. This reduces the Company's capacity to issue further Equity Securities
without Shareholder approval under those Listing Rules for the 12-month period following the
issue of the Placement Shares.
Listing Rule 7.4 provides an exception to Listing Rules 7.1 and 7.1A. It provides that where a
company in a general meeting ratifies the previous issue of securities made pursuant to Listing
Rules 7.1 and 7.1A (and provided that the previous issue did not breach Listing Rules 7.1 and
7.1A), those securities will be deemed to have been made with shareholder approval for the
purpose of Listing Rules 7.1 and 7.1A.
The effect of Shareholders passing Resolution 1(a) and (b) will be to allow the Company to
retain the flexibility to issue Equity Securities in the future up to the 15% placement capacity set
out in Listing Rule 7.1 and the 10% additional placement capacity set out in Listing Rule 7.1A,
without the requirement to obtain prior Shareholder approval.
If Resolution 1(a) is passed, 12,000,000 Placement Shares will be excluded in calculating the
Company's 15% limit in Listing Rule 7.1, effectively increasing the number of Equity Securities
it can issue without Shareholder approval over the 12-month period following the issue date.
If Resolution 1(a) is not passed, 12,000,000 Placement Shares will continue to be included in
the Company's 15% limit under Listing Rule 7.1, effectively decreasing the number of Equity
Securities the Company can issue or agree to issue without obtaining prior Shareholder
approval, to the extent of 12,000,000 Equity Securities for the 12-month period following the
issue of those Placement Shares.
Page 8
3475-1604-5877, v. 4
If Resolution 1(b) is passed, 8,000,000 Placement Shares will be excluded in calculating the
Company's additional 10% limit under Listing Rule 7.1A, effectively increasing the number of
Equity Securities it can issue without Shareholder approval over the 12-month period following
the issue date.
If Resolution 1(b) is not passed, 8,000,000 Placement Shares will continue to be included in the
Company's additional 10% limit under Listing Rule 7.1A, effectively decreasing the number of
Equity Securities the Company can issue or agree to issue without obtaining prior Shareholder
approval, to the extent of 8,000,000 Equity Securities for the 12-month period following the issue
of those Placement Shares (and assuming the Company's approval under Listing Rule 7.1A
remains in force for this period).
3.3
Specific information required by Listing Rule 7.5
Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in
relation to the ratification of the issue of the Placement Shares:
3.4
(a)
The Placement Shares were issued to professional and sophisticated investors, none
of whom is a related party of Material Investor of the Company. The participants were
identified through a bookbuild process, which involved the Lead Manager, seeking
expressions of interest to participate in the Placement from existing contacts of the
Company and clients of the Lead Manager.
(b)
A total of 20,000,000 Placement Shares were issued under Listing Rules 7.1 and 7.1A
in the proportions set out in Section 3.1.
(c)
The Placement Shares are fully paid ordinary shares and rank equally in all respects
with the Company’s existing Shares on issue.
(d)
The Placement Shares were issued on 14 February 2025 at an issue price of $0.05
each.
(e)
The proceeds from the Placement have been or are intended to be used for ongoing
costs associated with the Company’s potential acquisition of EAU Lithium, and for
working capital purposes (including costs of the Placement).
(f)
There are no other material terms to the agreement for the subscription of the
Placement Shares.
(g)
A voting exclusion statement is included in this Notice.
Additional information
Resolution 1(a) and (b) are separate ordinary resolutions.
The Board recommends that Shareholders vote in favour of Resolution 1(a) and (b).
4.
Resolution 2 – Approval to issue Director Placement Shares
4.1
General
The background to the proposed issue of Director Placement Shares is summarised in Section
3.1 above.
Page 9
3475-1604-5877, v. 4
Messrs James Bahen and Jeremy Robinson, both a Director of the Company, have committed
a total of $250,000 (before costs) under the Placement (together, the Participating
Directors). The Director Placement Shares will be issued in the following proportions:
Director
Amount committed
Number of Director
Placement Shares
James Bahen
$50,000
1,000,000
Jeremy Robinson
$200,000
4,000,000
TOTAL
$250,000
5,000,000
Resolution 2(a) and (b) (inclusive) seek the approval of Shareholders pursuant to Listing Rule
10.11 for the issue of up to 1,000,000 Director Placement Shares to Mr James Bahen (or his
nominee/s) and 4,000,000 Director Placement Shares to Mr Jeremy Robinson (or his
nominee/s) .
4.2
Listing Rule 10.11
Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a
listed company must not issue or agree to issue Equity Securities to any of the following
persons without the approval of its Shareholders:
(a)
a related party (Listing Rule 10.11.1);
(b)
a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (30%+) in the company (Listing Rule 10.11.2);
(c)
a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (10%+) in the company and who has nominated a director to the
board of the company pursuant to a relevant agreement which gives them a right or
expectation to do so (Listing Rule 10.11.3);
(d)
an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3 (Listing Rule
10.11.4); or
(e)
a person whose relation with the company or a person referred to in Listing Rule
10.11.1 or 10.11.4 is such that, in ASX's opinion, the issue or agreement should be
approved by its shareholders (Listing Rule 10.11.5).
The Participating Directors are related parties of the Company by virtue of being Directors.
Shareholder approval pursuant to Listing Rule 10.11 is therefore required unless an exception
applies. It is the view of the Board that the exceptions set out in Listing Rule 10.12 do not
apply in the current circumstances.
Approval pursuant to Listing Rule 7.1 is not required for the issue of the Director Placement
Shares as approval is being obtained under Listing Rule 10.11. Accordingly, the issue of the
Director Placement Shares to the Participating Directors (or their respective nominee/s) will
not be included in the Company's 15% annual placement capacity pursuant to Listing Rule
Page 10
3475-1604-5877, v. 4
7.1.
The effect of Shareholders passing Resolution 2(a) and (b) (inclusive) will be to allow the
Company to issue the Director Placement Shares to the Participating Directors (or their
respective nominee/s), raising $250,000 (before costs).
If Resolution 2(a) and (b) (inclusive) are not passed, the Company will not be able to proceed
with the issue of the Director Placement Shares to the Participating Directors (or their
respective nominee/s) under the relevant Resolution, and will not receive the additional
$250,000 (before costs) committed by the Participating Directors.
4.3
Specific information required by Listing Rule 10.13
Pursuant to and in accordance with Listing Rule 10.13, the following information is provided in
relation to the proposed issue of the Director Placement Shares:
4.4
(a)
The Director Placement Shares will be issued to Mr James Bahen and Mr Jeremy
Robinson (or their respective nominee/s) in the proportions set out in Section 4.1
above.
(b)
The Participating Directors each fall into the category stipulated by Listing Rule
10.11.1 by virtue of being Directors of the Company. In the event the Director
Placement Shares are issued to a nominee of a Participating Director, that nominee
will fall into the category stipulated by Listing Rule 10.11.4.
(c)
A maximum of 5,000,000 Director Placement Shares will be issued to the Participating
Directors (or their respective nominee/s) in the proportions set out in Section 4.1
above.
(d)
The Director Placement Shares are fully paid ordinary shares in the capital of the
Company and rank equally in all respects with the Company's existing Shares on
issue.
(e)
The Director Placement Shares will be issued no later than one month after the date
of the Meeting.
(f)
The Director Placement Shares will be issued at $0.05 each, being the same issue
price as the other Placement Shares to raise up to $250,000 (before costs).
(g)
A summary of the intended use of funds raised from the Placement is in Section 3.3(e)
above.
(h)
The proposed issue of the Director Placement Shares is not intended to remunerate or
incentivise the Participating Directors.
(i)
There are no other material terms to the proposed issue of the Director Placement
Shares.
(j)
A voting exclusion statement is included in the Notice.
Section 195 of the Corporations Act
Section 195(1) of the Corporations Act prohibits a director of a public company who has a
material personal interest in a matter that is being considered at a meeting of directors from
Page 11
3475-1604-5877, v. 4
being present while the matter is being considered at the meeting or voting on the matter. If
there is not a quorum of directors who are eligible to vote on a matter because of the operation
of section 195(1) of the Corporations Act, one or more directors may call a general meeting
and the general meeting may deal with the matter.
The Participating Directors each have a personal interest in the outcome of each of their
respective Resolutions under Resolution 2(a) and (b) and have exercised their right under
section 195(4) of the Corporations Act to put the proposed issue of the Director Placement
Shares to Shareholders to resolve.
4.5
Chapter 2E of the Corporations Act
In accordance with Chapter 2E of the Corporations Act, in order to give a financial benefit to a
related party, the Company must:
(a)
obtain Shareholder approval in the manner set out in section 217 to 227 of the
Corporations Act; and
(b)
give the benefit within 15 months following such approval,
unless the giving of the financial benefit falls within an exception set out in sections 210 to 216
of the Corporations Act.
The proposed issue of the Director Placement Shares constitutes giving a financial benefit to
related parties of the Company.
The Board considers that Shareholder approval pursuant to Chapter 2E of the Corporations
Act is not required in respect of the issue of the Director Placement Shares because the
Director Placement Shares will be issued on the same terms as those Placement Shares
issued to non-related party participants in the Placement and as such the giving of the
financial benefit is on arm's length terms.
4.6
Additional information
Resolution 2(a) and (b) (inclusive) are separate ordinary resolutions.
The Board (with James Bahen and Jeremy Robinson abstaining) recommend that
Shareholders vote in favour of Resolution 2(a) and (b) (inclusive).
5.
Resolution 3 – Approval to issue Lead Manager Options
5.1
General
The background to the Placement is summarised in Section 3.1 above.
The Lead Manager acted as lead manager to the Placement and will be issued 4,000,000
Options as partial consideration for their services (Lead Manager Options). The Lead
Manager Options are exercisable at $0.08 each and expire 8 August 2027 and are otherwise
subject to the terms and conditions in Schedule 2.
Resolution 3 seeks Shareholder approval pursuant to Listing Rule 7.1 for the issue of up to
4,000,000 Lead Manager Options to the Lead Manager (or its nominee/s).
Page 12
3475-1604-5877, v. 4
5.2
Summary of Lead Manager Mandate
The Company entered into a mandate with the Lead Manager for the provision of lead
manager services, including the coordination and management of the Placement (Lead
Manager Mandate).
Under the Lead Manager Mandate, the Company agreed to pay the Lead Manager:
(a)
a capital raising fee of 6% of the amount raised under the Placement (before costs);
and
(b)
by issuing the Lead Manager Options.
The Lead Manager Mandate contains additional provisions, including warranties and
indemnities in respect of the Company, which are considered standard for agreements of this
nature.
5.3
Listing Rule 7.1
A summary of Listing Rule 7.1 is summarised in Section 3.2 above.
The issue of the Lead Manager Options does not fall within any of the exceptions to Listing
Rule 7.1 and exceeds the 15% limit. It therefore requires the approval of Shareholders
pursuant to Listing Rule 7.1. Accordingly, Resolution 3 seeks Shareholder approval for the
issue of the Lead Manager Options under and for the purposes of Listing Rule 7.1.
If Resolution 3 is passed, the Company will be able to proceed with the issue of the Lead
Manager Options. In addition, the Lead Manager Options will be excluded from the calculation
of the number of Equity Securities that the company can issue without Shareholder approval
under Listing Rule 7.1.
If Resolution 3 is not passed, the Company will not be able to proceed with the issue of the
Lead Manager Options and will have to consider alternative commercial means to pay the
Lead Manager.
5.4
Specific information required by Listing Rule 7.3
Pursuant to and in accordance with Listing Rule 7.3, the following information is provided in
relation to the proposed issue of the Lead Manager Options:
(a)
The Lead Manager Options will be issued to the Lead Manager (or their respective
nominee/s) in the matter set out in Section 5.1 above.
(b)
A maximum of 4,000,000 Lead Manager Options will be issued.
(c)
The Lead Manager Options are exercisable at $0.08 each, expiring on 8 August 2027
and are otherwise subject to the terms and conditions in Schedule 2.
(d)
Shares issued upon exercise of the Lead Manager Options will be fully paid ordinary
Shares in the capital of the Company and will rank equally in all respects with the
Company’s then existing Shares on issue.
(e)
The Lead Manager Options will be issued no later than three (3) months after the date
of the Meeting.
Page 13
3475-1604-5877, v. 4
5.5
(f)
The Lead Manager Options will be issued with a nominal issue price of $0.00001 each
as partial consideration for the Lead Manager providing lead managerial and
bookrunner services in connection with the Placement. Accordingly, only $40 will be
raised by the issue of the Lead Manager Options and will be used towards general
working capital purposes.
(g)
A summary of the material terms of the Lead Manager Mandate is in Section 5.2
above.
(h)
A voting exclusion statement is included in the Notice.
Additional information
Resolution 3 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 3.
6.
Resolution 4 – Approval to issue Consideration Shares
6.1
General
On 19 December 2024, the Company announced that it had entered into an exclusive option
agreement to acquire 100% of the issued share capital of EAU Lithium Pty Ltd (EAU Lithium)
(EAU Option) from the shareholders of EAU Lithium (Vendors) (EAU Option Agreement).
A summary of the material terms of the EAU Option Agreement are set out in Section 6.2.
Resolution 4 seeks Shareholder approval pursuant to Listing Rule 7.1 for the issue of up to
109,000,000 Shares to the Vendors (or their respective nominee/s) (Consideration Shares).
6.2
Summary of the EAU Option Agreement
The material terms of the EAU Option Agreement are summarised below:
(a)
(Option Fee): The Company paid an initial option fee of $150,000 to the Vendors in
consideration for being granted the EAU Option.
(b)
(Option Period): The EAU Option is exercisable by the Company at any time for a
period of 12 months and may be extended by mutual agreement between the parties.
(c)
(Consideration): If the Company elects to exercise the EAU Option, the Company has
agreed to make a total cash payment of $525,000 and issue the Consideration Shares
(the subject of Shareholder approval pursuant to this Resolution 4).
(d)
(Vendor): The Vendors are the shareholders of EAU Lithium, none of which are a
related party of the Company.
(e)
(Board nomination): Upon exercise of the EAU Option, EAU Lithium will have the right
to appoint two directors to the Board (subject to the Board comprising of no more than 4
Directors).
The EAU Option Agreement contains warranties,
Share your feedback
Discover